Evidence map›Paper›PMID 24217253›Full record

ArticleThe Journal of biological chemistry2013

Biochemical and functional characterization of the klotho-VS polymorphism implicated in aging and disease risk.

Tracey B Tucker Zhou, Gwendalyn D King, CiDi Chen, Carmela R Abraham

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. FGF23 contains two distinct high-affinity binding sites enabling bivalent interactions with α-Klotho.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Klotho: An Elephant in Aging Research.The journals of gerontology. Series A, Biological sciences and medical sciences · 2019
    Review
  12. Klotho, the Key to Healthy Brain Aging?Brain plasticity (Amsterdam, Netherlands) · 2018
    Review
  13. Review
  14. Article
  15. Modeled structural basis for the recognition of α2-3-sialyllactose by soluble Klotho.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  16. Article
  17. Soluble klotho binds monosialoganglioside to regulate membrane microdomains and growth factor signaling.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  18. Review
  19. Article
  20. Variation in longevity gene KLOTHO is associated with greater cortical volumes.Annals of clinical and translational neurology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tracey B Tucker ZhouFrom the Departments of Pharmacology and Experimental Therapeutics and.
Gwendalyn D King
CiDi Chen
Carmela R Abraham
Boston University · US

Funding

STRUCTURAL STUDIES IN THE CENTRAL NERVOUS SYSTEMP01AG000001 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENE, DOUGLAS L · 1985 to 2013
$20.7M
TRAINING IN BIOMOLECULAR PHARMACOLOGYT32GM008541 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1997 to 2022
$5.2M
NIA NIH HHS AG 00001NIA NIH HHS P01 AG000001NIGMS NIH HHS 5T32GM008541-15NIGMS NIH HHS T32 GM008541
6 · The paper itself

Abstract

Klotho (KL) is an age-regulating protein named after the Greek goddess who spins the thread of life. Mice deficient in KL are normal throughout development, but rapidly degenerate and display a variety of aging-associated abnormalities that eventually lead to decreased life expectancy. While multiple genetic association studies have identified KL polymorphisms linked with changes in disease risk, there is a paucity of concrete mechanistic data to explain how these amino acid substitutions alter KL protein function. The KLVS polymorphism is suggested to lead to changes in protein trafficking although the mechanism is unclear. Our studies have sought to further investigate the functional differences in the KLVS variant that result in increased risk of many age-related diseases. Our findings suggest that the F352V and C370S substitutions lead to alterations in processing as seen by differences in shedding and half-life. Their co-expression in KLVS results in a phenotype resembling wild-type, but despite this intragenic complementation there are still changes in homodimerization and interactions with FGFR1c. Taken together, these studies suggest that KLVS leads to altered homodimerization that indirectly leads to changes in processing and FGFR1c interactions. These findings help elucidate the functional differences that result from the VS polymorphism, which will help clarify how alterations in KL function can lead to human disease and affect cognition and lifespan.

Indexed as

Polymorphism, Single NucleotideAgingAging, PrematureGenetic Predisposition to DiseaseGlucuronidaseHEK293 CellsHumansKlotho ProteinsMutation, MissenseProtein MultimerizationProtein TransportReceptor, Fibroblast Growth Factor, Type 1FGFR1 protein, humanGlucuronidaseKlotho ProteinsReceptor, Fibroblast Growth Factor, Type 1AgingCell SignalingDimerizaionFibroblast Growth Factor Receptor (FGFR)Genetic PolymorphismProtein ComplexesShedding

Identifiers

PMID24217253
PMCPMC3868745
OpenAlexW2029666578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.